What is the true incidence of COVID-19 in patients with rheumatic diseases?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

61 citing papers in PubMed.

1. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis.Arthritis research & therapy · 2020
   Trial
2. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.Journal of autoimmunity · 2020
   Trial
3. Cross-sectional study of COVID-19 infection in patients with rheumatic diseases in a sample of a Damascene population, Syria.Annals of medicine and surgery (2012) · 2023
   Article
4. Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study.Seminars in arthritis and rheumatism · 2022
   Observational
5. Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases.The Egyptian rheumatologist · 2022
   Article
6. Can anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?Advanced pharmaceutical bulletin · 2022
   Article
7. Coronavirus disease 2019 in patients with Behcet's disease: a report of 59 cases in Iran.Clinical rheumatology · 2022
   Article
8. Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.RMD open · 2022
   Article
9. COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.Fundamental & clinical pharmacology · 2022
   Article
10. Optimal biologics for juvenile idiopathic arthritis in an infection with SARS-CoV-2 α-variant.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
11. IFI44 is an immune evasion biomarker for SARS-CoV-2 andFrontiers in immunology · 2022
    Article
12. Prevalence of coronavirus disease 2019 in a multiethnic cohort of patients with autoimmune rheumatic diseases in Qatar.Qatar medical journal · 2022
    Article
13. The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.Frontiers in medicine · 2022
    Article
14. Attitudes of patients with spondylarthritis or rheumatoid arthritis regarding biological treatment during COVID-19 pandemic: A multi-center, phone-based, cross-sectional study.Archives of rheumatology · 2021
    Article
15. The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.Health science reports · 2021
    Review
16. COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis.Rheumatology international · 2021
    Review
17. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.Clinical rheumatology · 2021
    Article
18. Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea.BMJ open · 2021
    Article
19. Recent advances in antibody-based immunotherapy strategies for COVID-19.Journal of cellular biochemistry · 2021
    Review
20. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.Journal of autoimmunity · 2021
    Article

1 more citing papers are in PubMed but not listed here.

Corrections and comments

• Commented on by
  Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.2020

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as